The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1004
July 4, 1997
View Complete Issue         Table of Contents 2019 
Topical Butenafine for Tinea Pedis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Topical Butenafine for Tinea Pedis
July 4, 1997 (Issue: 1004)
Butenafine hydrochloride 1% cream (Mentax - Penederm), a benzylamine antifungal drug similar to the allylamines terbinafine (Lamisil) and naftifine (Naftin), is now available in the USA for topical treatment of tinea pedis, tinea corporis and tinea...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Topical Butenafine for Tinea Pedis
Article code: 1004c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.